1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Metastatic Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

SUMMARY
DelveInsight’s, “ Metastatic Pancreatic Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope:
- A snapshot of the global Market therapeutics scenario for Metastatic Pancreatic Cancer.
- A review of the marketed products under prescription for Metastatic Pancreatic Cancer, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Metastatic Pancreatic Cancer with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Metastatic Pancreatic Cancer drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Metastatic Pancreatic Cancer drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Metastatic Pancreatic Cancer drugs.
- Coverage of Metastatic Pancreatic Cancer Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure from 2011-2015.

Reasons to buy
- Evaluate the marketing status and exclusivity details of Metastatic Pancreatic Cancer key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Metastatic Pancreatic Cancer.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Metastatic Pancreatic Cancer.
- API intelligence over marketed drugs for Metastatic Pancreatic Cancer and gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Metastatic Pancreatic Cancer.
- Uncovering opportunities in the rapidly growing the US markets.

Table Of Contents

Metastatic Pancreatic Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
Table of Contents
- Indication Overview
- Marketed Drugs Assessment
- Marketed Details of Drugs by Application Type
- Marketed Details of Drugs (NDA) by Marketing Status
- Marketed Details of Drugs by Patent Expiration Timeline
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
- The API Manufacturers by the United States Drug Master File (US DMF) Status
- The API Manufacturers by the US DMF Status (Drug Specific)
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
- The API Manufacturers by the US DMF Status (Drug Specific)
- Drugs Market Data and Forecasted Sales Figures (2011-2015)
- Marketed Drugs Information
- Drugs Description
- Route of Synthesis
- Global Active Pharmaceutical Manufacturers
- Approval Status
- Patent and Exclusivity Details
- Company Overview
- Phase III Drugs Information
- Phase III Drugs Description
- The United States Drug Master Filings (US DMF)
- Discontinued Drugs Information


List of Tables

Metastatic Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Metastatic Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Metastatic Pancreatic Cancer Therapeutic Market, US, (Year), 2014
Metastatic Pancreatic Cancer Marketed Drugs, API Manufacturers by US DMF Status, 2014
Metastatic Pancreatic Cancer Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Metastatic Pancreatic Cancer Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Metastatic Pancreatic Cancer Therapeutic Market, Global Sales (in million USD), 2014
Metastatic Pancreatic Cancer Marketed Drugs, API Manufacturers, Global, 2014
Metastatic Pancreatic Cancer Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Metastatic Pancreatic Cancer, 2014?


List of Figures

Metastatic Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Metastatic Pancreatic Cancer Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Metastatic Pancreatic Cancer Therapeutic Market, US, (Year), 2014
Metastatic Pancreatic Cancer Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Metastatic Pancreatic Cancer Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Metastatic Pancreatic Cancer Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Metastatic Pancreatic Cancer Therapeutic Market, Global Sales (in million USD), 2014
Metastatic Pancreatic Cancer Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Pancreatic Cancer - Market Insights, Epidemiology and Market  Forecast-2023

Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2014 - 2025

Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • February 2017
  • by Grand View Research

The global pancreatic cancer treatment market is expected to reach USD 4.2 billion in 2025, according to a new report by Grand View Research, Inc. Increasing tobacco consumption, smoking, obesity, and ...

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2017 - 2022)

Global Pancreatic Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and Geography (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global pancreatic cancer market is expected to grow modestly from USD 1,730 million in 2015, growing at a CAGR of 10-17%. Globally, pancreatic cancer is the 12th most common cancer in men and 11th ...


Download Unlimited Documents from Trusted Public Sources

Lymphoma Statistics in Germany

  • March 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

Sexually Transmitted Disease Statistics and Cancer Statistics in the Netherlands

  • March 2017
    213 pages
  • Sexually Transm...  

    Cancer  

    Smoking Statist...  

  • Netherlands  

    Europe  

View report >

Related Market Segments :

Pancreatic Cancer

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.